Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Feagan

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
The Cochrane Database of Systematic Reviews|January 22, 2003
Methotrexate for induction of remission in refractory Crohn's diseaseA A Alfadhli, J W McDonald, B G Feagan
Alimentary Pharmacology & Therapeutics|March 30, 2011
Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegolB G Feagan, S B Hanauer, G Coteur, et al.
The Cochrane Database of Systematic Reviews|January 28, 2005
Methotrexate for induction of remission in refractory Crohn's diseaseA A F Alfadhli, J W D McDonald, B G Feagan
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 13, 1997
Intravenous cyclosporine for severe attacks of ulcerative colitis: a survey of Canadian gastroenterologistsK A Atkinson, J W McDonald, B Lamba, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2018
Editorial: validating reliability of the eosinophilic oesophagitis histological scoring system (EOE-HSS)-an important first step. Authors' replyR K Pai, A J Bredenoord, B G Feagan, et al.
The American Journal of Gastroenterology|August 19, 2000
Annual cost of care for Crohn's disease: a payor perspectiveB G Feagan, M G Vreeland, L R Larson, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 1, 1991
Use of acetylsalicylic acid by physicians and in the communityJ Mahon, K Steel, B G Feagan, et al.
American Journal of Hypertension|January 1, 1997
A randomized study comparing a patient-directed hypertension management strategy with usual office-based careK B Zarnke, B G Feagan, J L Mahon, et al.
Alimentary Pharmacology & Therapeutics|March 20, 2010
Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate-to-severe Crohn's disease in the PRECiSE 2 studyB G Feagan, M C Reilly, L Gerlier, et al.
Alimentary Pharmacology & Therapeutics|August 17, 2002
The effectiveness of budesonide therapy for Crohn's diseaseS V Kane, P Schoenfeld, W J Sandborn, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
The Cochrane Database of Systematic Reviews|January 22, 2003
Methotrexate for induction of remission in refractory Crohn's diseaseA A Alfadhli, J W McDonald, B G Feagan
Alimentary Pharmacology & Therapeutics|March 30, 2011
Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegolB G Feagan, S B Hanauer, G Coteur, et al.
The Cochrane Database of Systematic Reviews|January 28, 2005
Methotrexate for induction of remission in refractory Crohn's diseaseA A F Alfadhli, J W D McDonald, B G Feagan
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 13, 1997
Intravenous cyclosporine for severe attacks of ulcerative colitis: a survey of Canadian gastroenterologistsK A Atkinson, J W McDonald, B Lamba, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2018
Editorial: validating reliability of the eosinophilic oesophagitis histological scoring system (EOE-HSS)-an important first step. Authors' replyR K Pai, A J Bredenoord, B G Feagan, et al.
The American Journal of Gastroenterology|August 19, 2000
Annual cost of care for Crohn's disease: a payor perspectiveB G Feagan, M G Vreeland, L R Larson, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 1, 1991
Use of acetylsalicylic acid by physicians and in the communityJ Mahon, K Steel, B G Feagan, et al.
American Journal of Hypertension|January 1, 1997
A randomized study comparing a patient-directed hypertension management strategy with usual office-based careK B Zarnke, B G Feagan, J L Mahon, et al.
Alimentary Pharmacology & Therapeutics|March 20, 2010
Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate-to-severe Crohn's disease in the PRECiSE 2 studyB G Feagan, M C Reilly, L Gerlier, et al.
Alimentary Pharmacology & Therapeutics|August 17, 2002
The effectiveness of budesonide therapy for Crohn's diseaseS V Kane, P Schoenfeld, W J Sandborn, et al.
Pageof 8